Surgery does not improve survival outcomes in people with primary gastric lymphoma

Cancer Treatment Reviews

Volumn 31, Issue 1, 2005, Pages 49-52

  Avilés, Agustin ^a   Nambo, M J ^a   Neri, N ^a   Portlock, Carol S ^b  

^a Memorial Sloan Kettering Cancer Ctr ^*

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SIDE EFFECT; STOMACH HEMORRHAGE; STOMACH LYMPHOMA; STOMACH PERFORATION; STOMACH SURGERY; TISSUE SECTION; TUMOR BIOPSY;

EID: 13844276950     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2004.12.002     Document Type: Note

References (5)

1. N.L. Harris E.S. Jaffe J. Diebold et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997 Hematol J 1 2000 53-66
2. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-94
3. L.M. Staudt Molecular diagnosis of the hematologic cancers N Engl J Med 1 348 2003 1777-85
4. B. Coiffier E. Lepage J. Briere et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 24 346 2002 235-42
5. S.S. Yoon D.G. Coit C.S. Portlock M.S. Karpeh The diminishing role of surgery in the treatment of gastric lymphoma Ann Surg 240 2004 28-37